Cleared Traditional

K192702 - DePuy Synthes Craniomaxillofacial Neuro Devices - MR Conditional

K192702 is an FDA 510(k) clearance for DePuy Synthes Craniomaxillofacial Neuro..., manufactured by Synthes USA Products, LLC. The device is a Class 2 Neurology device with product code GXN cleared through the Traditional 510(k) pathway after a 357-day FDA review.

K192702 · Synthes USA Products, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
357d
Days
Class 2
Risk

K192702 is an FDA 510(k) clearance for the DePuy Synthes Craniomaxillofacial Neuro Devices - MR Conditional. Classified as Plate, Cranioplasty, Preformed, Non-alterable (product code GXN), Class II - Special Controls.

Submitted by Synthes USA Products, LLC (West Chester, US). The FDA issued a Cleared decision on September 18, 2020 after a review of 357 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5330 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Synthes USA Products, LLC devices

FDA 510(k) Submission Details - K192702

510(k) Number K192702 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2019
Decision Date September 18, 2020
Days to Decision 357 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
209d slower than avg
Panel avg: 148d · This submission: 357d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXN Device Classification - Class 2, Special Controls

Product Code GXN Plate, Cranioplasty, Preformed, Non-alterable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXN Plate, Cranioplasty, Preformed, Non-alterable

All 54
Devices cleared under the same product code (GXN) and FDA review panel - the closest regulatory comparables to K192702.
Longeviti PMMA Static Cranial Implant
K210616 · Longeviti Neuro Solutions, LLC · Mar 2021
Longeviti ClearFit Cranial Implant
K203349 · Longeviti Neuro Solutions, LLC · Dec 2020
Longeviti ClearFit Cranial Implant
K202901 · Longeviti Neuro Solutions, LLC · Oct 2020
CustomizedBone Service
K193547 · Fin-Ceramica Faenza S.P.A. · Jan 2020
Longeviti ClearFit Cranial Implant
K191210 · Longeviti Neuro Solutions, LLC · Jan 2020
OsteoFab Patient Specific Cranial Device
K180064 · Oxford Performance Materials, Inc. · Jul 2018